Form 4: Abeona Therapeutics CFO Joseph Vazzano Reports Stock Transaction
SEC Form 4
Joseph Vazzano, CFO of Abeona Therapeutics, reports disposition of shares to cover tax obligations upon vesting of restricted stock.
Summary
- On June 5, 2024, Joseph Vazzano, the Chief Financial Officer of Abeona Therapeutics Inc. (ABEO), reported a transaction involving the disposition of 16,408 shares of common stock.
- The shares were surrendered to satisfy tax withholding obligations upon the vesting of restricted stock.
- The transaction was executed at a price of $4.52 per share.
- Following the transaction, Vazzano directly owns 217,460 shares of Abeona Therapeutics.
- The disposition is exempt under Rule 16b-3(e).
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine transaction for tax obligations.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 06/05/2024 | Date of stock transaction |
| 06/07/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.